FDA NDC Directory · JSON-LD · Markdown

Risperidone

NDC 59746-030 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerJubilant Cadista Pharmacuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090839
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsRISPERIDONE (2 mg/1)
Marketing started20111104
Package count1

External sources

Source: openFDA. Public-domain (CC0).